Neocloud Ecosystem Cheat Sheet Part 1/2: Bullet Point Positive vs. Negatives. Full List by Marketcap: $CRWV ($66.2B) $NBIS ($32.85B) $IREN ($16.52B) $APLD ($9.69B) $RIOT ($7.34B) $CIFR ($7.3B) $WULF ($6.36B) $HUT($5.39B) $CLSK ($5.01B) $HIVE ($1.74B CAD) $WYFI ($1.29B) $WLAC($600m IPO) $DGXX ($393M CAD) $SLNH ($281.9M) _ Summary When comparing, a major source of alpha generation currently lies in the megawatt valuation arbitrage, which involves converting low-multiple Bitcoin power capacity into high-multiple AI hosting capacity. The second major alpha is margin generation, which involves being vertically integrated from the bottom up from GPU orchestration to software. Coreweave ( $CRWV ) - $66.2B Marketcap 🍏Positives ________________ - Sector leader by scale: quarterly revenue of $1.21B (+206.75% YoY) and EBITDA of $607.69M; on pace for $5B+ ARR in 2025. - $30B+ backlog, anchored by: - $14B Meta deal, - OpenAI - $6.3B NVIDIA GPU backstop agreement, - growng Gov contracts via CRWV Federal . - Expansion into U.S. government infrastructure is a major long-term moat if backstopped by federal workloads. - NVIDIA partnership ensures utilization floor; de-risks GPU oversupply. - Positioned as hyperscaler alternative with Tier 1 clients and national buildout footprint. Negatives ________________ - Aggressive capex: Q3 spend of $2.9–3.4B, with 2025 full-year guidance of $20–23B. - High-cost debt structure: Over $1B in projected annual interest, versus competors using low- or zero-interest convertible notes. - Q2 GAAP net loss of $291M, signaling limited profitability despite scale. - Execution risk remains high: e.g., failed $9B Core Scientific acquisition due to shareholder rejection. - Competitors like Nebius are closing the full-stack gap, weakening CoreWeave's software moat. Nebius ( $NBIS ) - $32.85B MarketCap 🍏Positives ________________ - $17.4B Microsoft deal for full-stack AI infrastructure (possibly rising to $19.4B). - Active include many enterprises such as MSFT, Shopify, Accenture, governments, and AI startups. - 71%+ gross margins on AI infra segment; profitable at the EBITDA level. - 1 GW+ powr secured, targeting dense GPU deployments across new sites. - Fully integrated software+hardware stack, which increases opex and is a moat. - $10B+ in assets, from $5.8B+ cash, ownership of companies like Clickhouse that powers Anthropic, Meta, and others growing rapidly. Negatives ________________ - Execution risks around full-stack delivery and latency SLAs could derail rollout. - Microsoft is the primary anchor on forward revenue extreme contract dependency (high concentration risk projected AI revenue) - 71% gross margin figure not representative of forward revenue or execution at scale and could lower to a more conservative 50-65% number. $IREN - $16.52B marketcap 🍏Positives ________________ - 2.91 GW power secured, diversified across North America, and expanding more than 3GW in renewable power capacity. - Full control over power, land, and data center construction = vertical efficiency and higher margin control compare to other bare metal. - Targets customers (e.g., AI labs, hyperscalers) who might bring their own Type-1 orchestration and prefer bare-metal control. - Historically the most efficient and profitable large-scale BTC miner and better positioned to handle rising GPU power/cooling requirements in B100/B200 generations for AI cloud pivot. - Targeting an ARR of over $500 million by the first quarter of 2026 by buildouting out a fleet of 23,000 NVIDIA B200/B300 + AMD MI350X GPUs. Downsides ________________ - No well-known enteprsie/hyperscaler contract visibility and limited disclosed large SLA deals yet - Not a full-stack provider; acts as Tier-1 (shell/colocation) = lower margin and tenant risk and illustrative GPU target. Meaning it is unable to capture the highest-margin revenues associated with integrated, proprietary full-stack cloud - Quoted 92% margins excludes expense recognition, and with D&A and would be much lower at scale. - The substantial capital expenditure required for the large-scale GPU purchase risks negative returns if future utilization rates fail to meet expectations $APLD 🍏Positives ________________ - $5B Macquarie financing facility, with first draw building 400MW AI campus. - Tenant: CoreWeave fully leasing Polaris Forge 1 (400MW), scalable to 1GW. - Proprietary waterless liquid cooling optimized for dense AI workloads - Capex-light via preferred equity. - AI-first buildout focused on latency, fiber, and power pairing in North Dakota. Downsides ________________ - Large-scale buildout depends on continued draws from Macquarie’s $5B facility. - 400MW CoreWeave lease is all-or-nothing; no clarity on tenant diversity. - Execution risk at Polaris Forge: weather, zoning, grid integration delays. - Exposed to single-tenant concentration and private-market GPU pricing dynamics. $RIOT 🍏Positives ________________ - 600MW idle capacity in Corsicana, TX under AI redeployment review. - Gigawatt-scale infrastructure in place, ready for rapid pivot. - Leverages one of the lowest power costs in the U.S. (ERCOT access). - TTM Gross Margin of nearly 60% as of Q2 2025, primarily derived from its core mining business. The successful implementation of this contract gives more confidence in converting additional existing mining sites into high-multiple HPC capacity. Negatives ________________ - AI pivot is purely exploratory; no firm buildout announced. - 600MW idle capacity = opportunity, but also dead capital for now. - Canceling mining expansion (8.3 EH/s) may weaken near-term revenues. - Needs permits, fiber, GPU supply, and anchor tenant before AI rollout can begin. $CIFR 🍏Positives ________________ - 10-year, $3B+ computing 168MW agreement with Fluidstack + $GOOGL - Agreement is substantially de-risked by a $1.4 billion commitment from Google to backstop the Fluidstack lease - High-margin, low-risk hosting model with leased facilities. Negatives ________________ - Fluidstack deal is 10-year but fixed-price, limiting upside if GPU rental rates increase. - $1.3B convertible debt adds dilution risk if equity markets weaken. - Site buildouts dependent on few customers, very high fill and utilization risk. _ Since the data center sector is so nuanced and broad thought it would be helpful if I wrote created a full TLDR list for newcomers to see the tradeoffs of each approach. I'll probably go back and add more stuff to $CIFR and $APLD and others in one final post since it didn't get enough justice. I just didn't realize how much time this took to write up + please correct me if any figures are off lol. Also would save me time if people helped fill out the rest lol so would appreciate it too for 2/2. ~~~ Help with the Crowdsourcing ~~~

As expected, with META and their recent 14B deal with CRWV + MSFT with their 17B deal with $NBIS, billions to trillions will pour into Neoclouds from Mag7 when they're unable to handle new AI compute. Expects companies like AWS, ORCL and others to make more deals soon with companies like $CIFR or $IREN soon. This is a once in a generation opportunity to buy tiny new Neocloud companies that serve as the infrastructure of multi-trillion Hyperscaler cash cows.

The Neocloud thesis aged well. 1 month later: $CRWV 120.34 → 135.64 (+12.7%) $NBIS 107.70 → 126.49 (+17.5%) $WULF 10.63 → 13.69 (+28.8%) $IREN 41.68 → 64.69 (+55.2%) $CIFR 11.47 → 20.70 (+80.4%) $BITF 2.54 → 4.51 (+77.6%) $WYFI 22.83 → 36.52 (+59.9%) $GRRR 19.90 → 16.95 (−14.8%) $SLNH 2.75 → 2.81 (+2.2%) $RIOT 17.69 → 23.01 (+30.1%) $MARA 16.13 → 19.61 (+21.6%) $CLSK 12.96 → 20.21 (+56.0%) $HUT 33.16 → 49.95 (+50.6%) This is only the beginning of the largest AI data center buildout in history and everyone on finx is still early. I'm very bullish on the Neocloud sector across the board, but personally have concentration in $NBIS due to the highest asymmetrical return.

Neocloud Position Update Friday Oct 24. This post is to send a message to $IREN and other Neoclouds holders that: 👑 $NBIS is superior. I sold out of other Neoclouds: $CIFR 250%+ gain, $IREN, $BITF, $WYFI, 50-100%+ gain, $WULF 5-10% loss. Now with $2M+ exposure in $NBIS shares/leaps + small $WLAC positions. Will add more Nebius positions next week if it stays at $115. I don't normally post sales, but there's a lot of annoying Neocloud posts recently claiming that theirs is the best. So I'm posting this to send a message that $NBIS is clearly superior in terms of asymmetrical upside and already has Mag7 deals locked in. And because of this, there's no point of diversifying into other Neoclouds. NBIS will likely have the highest margin moat from how they do full stack/GPU utilization with their diversified users. And their subsidiaries + portfolio companies (AI DBs, robotics/delivery, etc). are scaling alongside their operational business. There's also no exposure to bad interest debt that eats into margins. There's an easy path to 300% gain and a $100B+ marketcap just by waiting 1 year for another hyperscaler contract and there's no point in speculating gross margins from Bitcoin mining pivots (see how $ORCL lost $100M+ just bc of GPU utilization + buildout -> rev lag) even if some might have larger capacity. So just wanted to say: Nebius is THE Neocloud. 🫳🎙️

If you have any iota of doubt during this market correction. Remember this: $NBIS is a $24B MC company doing $8B forward ARR, targeting 30% EBITDA margins. Nebius core business powers Mag7 Hyperscalers from $MSFT to $META, enterprises from Shopify to Cursor to Accenture, and Government AI Infrastructure. They have $10B+ NAV with hyper-growth portfolio companies powering Cloudflare, Tiktok, Tesla, Netflix and Antrophic. And of course, Nebius is growing 700%+ Y/Y, which is almost unheard of going from $125M quarterly revenue to $2B+ in just 1 year. This company is the at the Center of the whole Artificial Intelligence buildout at $93, and is set to be the next $100B+ company. Do not let broad sell-offs affect your conviction.

Nebius is playing out exactly how institutions wanted: Retail panic. Capitulation. Liquidity. I’ve been saying this for weeks: $NBIS Institutional ownership is ~38%. Every trick in the book will be used to get that number to 65-80% like $HOOD: Here's what and why this is happening: Nebius got put on Wall Street's radar after the MSFT 17-19 billion dollar deal last month. Before then institutional ownership was sitting in <30%'s due to a non-traditional public listing. Meanwhile we were able to see Nebius's fundamentals exploding: 1. 🚀 1,000%+ forward revenue growth with 55-75% gross margins to 4-6B+ ARR. 2. 💼 Large ownership of companies like Clickhouse powering Anthropic, Meta, Lyft, etc. 3. ⚡ NBIS powering Microsoft Azure + likely more Mag7 infrastructure, the cash cows of Hyperscalers 4. 🌊 Huge moat from full-stack + software GPU orchestration, leading to higher gross margins. 5. 💸 Largest datacenter builtout in history, with Meta signing deals with CRWV, and other hyperscalers following-suit. We've seen forward projections with TSM on this buildout, and they're blowout numbers. 6. 🏦 3X rate cuts boosting forward revenue projections. Nebius is a screaming buy and a once-in-a-generational company in the marketing as a $26B company and $100/share. We've seen this play with Robinhood, when they would have 50% below MC price targets, hit-pieces when share price was $20. Yet Robinhood grew from $150m quarterly revenue to $950m-1B, and market cap went from $15B to $130B and then became the darling of Wall Street. Wall Street and institutional investors see this clearly with Nebius for the next year but don't have large positions yet. However, retail only sees the dropping price, sensationalist articles about Oracle losing $100m trying to enter the space, and the current 100M revenue numbers instead of the projected $1B+/quarter. So, even if price can seem like they're dropping off marginal trades are executed at lower prices, even if more shares get bought: 1. Retail panic-sells, gets margin liquidated. 2. Mechanical hedging from MM's from short-dated options (couterparty to retail selling CSPs or buying short dated calls) exacerbates downside, creating a sell-off) 3. MMs from Citadel to Virtu absorb the flow by buying from retail. 4. MMs hedge + rebalance by offload to insitutions in block trades + dark pools. (harvesting selloff by institutions) 5. Institutions get low-visibility accumulation while keeping price down. (eg. 100k shares sold by retail, and 150k shares bought by institutions, while price drops.) Retail sees "red days" and thinks "no one’s buying" while accumulation continues quietly. Retail sentiment is collapsing but fundamentals have only improved (eg. new Israel data center build out for more ~80m+ ARR based on estimates). It's a slow, strategic process to accumulate a large percentage of a company's float as hedge funds and institutions see Nebius as a potential next 100B+ company. The fundamentals haven’t changed - only the share price and retail sentiment have.

The harsh reality is: Many of these HPC miner pivots will fail. The lack of asymmetrical upside is why I sold off miners like $CIFR, $IREN, $WYFI, and $WULF and into full-stack AWS Neoclouds like $NBIS However, miners that pivot well like $CRWV have very high upside 📈 Why? As a trader, I rode almost every single Neocloud from $BITF to $IREN as a narrative momentum trade. And most are up 50%-250%+. But none of them aside from $CRWV have contracted AI workloads or cash-flow visibility at scale. Currently, many just look at Coreweave when it comes time to execution. When the new report that $ORCL, a $800B hyperscaler, lost $100M on their buildout and only had 14% gross margins, this should have sent alarm bells regarding moats, buildout risks, and margins. I took this as a lesson that HPC is actually a huge moat and gross margins matter a ton more than capacity buildout. These tradeoffs are what people should think of when weighing the execution risk when putting money into $200M market caps like $SLNH. This is not a bear post, I am still bullish on the Neocloud buildout as a whole, this about execution risks and the reality of the situation. However, my guess is: The market will price this in before earning reports come out and margins are scrutinized. We will likely see several popular names sell-off and consolidate into the Neocloud winners whether that's $NBIS or $IREN, and people are free to speculate which one will succeed. The reality is when there's a new emerging market, not every company succeeds. But if you choose the right winner like $NVDA, there's generational returns. I just started early, selling off many miners like $CIFR to $SLNH to $IREN to $BITF and consolidating into likely winners like $NBIS. When Nebius already has hyperscaler contracts + large moats in full stack + high gross margins + high cash balances + subsidiaries, the downside risk is a lot less, and the asymmetrical upside is a lot higher.

The Neocloud thesis aged well. 1 month later: $CRWV 120.34 → 135.64 (+12.7%) $NBIS 107.70 → 126.49 (+17.5%) $WULF 10.63 → 13.69 (+28.8%) $IREN 41.68 → 64.69 (+55.2%) $CIFR 11.47 → 20.70 (+80.4%) $BITF 2.54 → 4.51 (+77.6%) $WYFI 22.83 → 36.52 (+59.9%) $GRRR 19.90 → 16.95 (−14.8%) $SLNH 2.75 → 2.81 (+2.2%) $RIOT 17.69 → 23.01 (+30.1%) $MARA 16.13 → 19.61 (+21.6%) $CLSK 12.96 → 20.21 (+56.0%) $HUT 33.16 → 49.95 (+50.6%) This is only the beginning of the largest AI data center buildout in history and everyone on finx is still early. I'm very bullish on the Neocloud sector across the board, but personally have concentration in $NBIS due to the highest asymmetrical return.

Northland announced a $NBIS $205 price target off the assumption of $2-4B ARR for CY2026 back in September. From their same economics used, we would now get an 1Y PT: ~$355.00/share (+248.04%) off Nebius's earnings report with $7-9B ARR projected Here's the updated metrics: Northland Capital Markets 09/24/2025 report, their CY2026 scenario assumed: ARR: raised from $2-4B Revenue: $2.3B Adjusted EBITDA: $907M EV/Sales multiple: 23.8× for the core AIaaS business. Shares outstanding: ~290 M Equity value per share: $205PT New Nebius fundamentals (Q3 2025 release): CY2026 ARR ≈ $8 B (midpoint), Revenue ≈ $4.6 B, and proportional EBITDA scaing (~$1.8 B). Keeping their EV/Sales ≈ 23.8×, new core EV ≈ $4.6 B × 23.8 = $109 B. Add the subsidiaries (≈ $7 B total from Northland’s sum of parts) and net cash (~$0.7 B) -> total equity ≈ $117 B → ~$355 PT It's a mechanical extrapolation assuming valuation multiples for their analysis, not the analyst updated PT that might change based on dilution/execution risks, etc. 2-3x of $NBIS CY2026 ARR from the analyst's 2-B estimate to the new management guidance midpoint of $8.0 billion mechanically drives the valuation higher The updated price target is based on a re-run of the DCF model.

We're seeing a sector crash in high-beta AI stocks, with names down 30-45%+ in 1M & 10%+ today. This includes direct beneficiaries of Mag7 Capex : - Nebius ( $NBIS ): $3B $META deal / $8B forward ARR. - TeraWulf ( $WULF ): <$50B Antrophic DC + JV FS/ $GOOGL - Iren ( $IREN ): $9B $MSFT HPC - Cipher ( $CIFR ): 15Y $5.5 billion w/ $AMZN. that improved their fundamentals in this past month alone. But markets are still panic selling names from $CRDO (-10.33% 1D) to $CIFR (-7.28% 1D) despite record forward revenue growth. This is driven over fears from macro (shutdown, Dec rate cut, corporate bond spreads, etc) and false (but nuanced) institutional claims eg. Burry on GPU depreciation, rather than individual fundamentals. This wipes away froth from the speculative parts of the AI sector such as $OKLO (energy, -37% 1M), but higher-margin growth names get caught together with it. I've said this before, but this reminds me of the time $HOOD sold off to $28 from $65 then pulled off a rally to $150. Or when $ALAB sold off from $100 to $50 off all earnings beats, then rallied to $245. Sometimes stock prices get detached from fundamentals when there’s fear in the markets, especially with “AI bubble” fears like what's happening now. But when the forward growth backs up any market cap projections, it’s just a matter of time and execution.

Ignore the noise and hold positions/add in market winners. You have: - Insane forward revenue growth from Neoclouds like $NBIS, $IREN, $CIFR - Record high CapEX projections from Mag7 earnings like $META to $MSFT - Record high forward revenue projections + margin growth from semiconductors like $TSM. If fundamentals are in tact, news headlines like "The AI Party is Over" is BS. We'll likely see a major recovery when government shutdown ends. This is likely a short-term correction pricing in a few things such as no third rate cut (86% -> 70%, still likely) + government shutdown extending past the 16th (53% chance, 30% chance 2 days ago) per contract markets.

Added $200k worth of $NBIS leaps at $98.8, December $105 2026 strike. Nebius dropping 30%+ in a week from $140 to $97 might make you second-guess yourself, but it’s times like these where conviction matters most. If you understand the fundamentals and sector, this is a gift.

long $SPRB. my price target is $500. rare disease is my specialty. the ERT for Sanfilippo will be approved (CMC notwithstanding) and be the new standard of care.

Wow, $NBIS just blew away ARR expectations on growth and just signed a surprisising $3B hyperscaler deal with $META from their ER. They now expect $7-9B ARR 2026, which is ~2.1B+ revenue/quarter. This is exactly how Nebius grows grow to a $100B MC and $NBIS is a generational company in the making. In terms of general earnings: EPS: -.52 vs -.4 (Beat by 23%) Revenue 155.73m vs. 141.1M (Miss by 6%) Markets are forward looking and any short term ER will be overshadowed by its immense forward growth projection. Will do a deeper rundown when there's more time to process information but so far, this is incredibly huge with a surprise hyperscaler deal. Stock should be up way above these levels when markets price this in.

🧙‍♂️ Summoning Exodia, the ideal Neocloud Deck Exodia Deck: 🧩 $NBIS – Head 🧩 $WLAC – Left Arm 🧩 $IREN – Right Arm 🧩 $CIFR – Left Leg 🧩 $WULF – Right Leg Pot of Greed Setup: 🏭 $TSM ⚡ $FLNC 🏡 $GLXY When all five are in your port, Sydney Sweeney descends from the Neocloud

Institutional Flow assessment for 13F Neocloud filings: · Nebius ( $NBIS ): 🟢 Strongly Positive (7/10) · WULF ( $WULF ): 🟢 Highly Positive (8.5/10) · IREN ( $IREN ): 🔴 Very Negative (3/10) · CIFR ( $CIFR ): 🟢 Highly Positive (8.0/10) · Coreweave ( $CRWV ): 🟡 Neutral (5.5/10) · Cleanspark ( $CLSK ): 🟢 Highly Positive (9.0/10) _ TLDR Summary Updates: $NBIS · Strong overall quantitative growth in institutional ownership, driven by a mix of solid, long-term institutional buyers alongside high activity from quantitative funds and hedge funds. $WULF · Structurally stable and secure institutional base, characterized by large, long-only asset managers like Vanguard and BlackRock who hold high conviction in the stock. $IREN · Ownership is dominated by high-frequency traders, market makers, and quant funds (eg. Jane Street, Citadel). This structure is viewed negatively as it suggests less stable, short-term holding pressure and a lack of conviction from long-term institutions. $CIFR · Excellent institutional setup marked by inclusion in major indices (passive demand) and strong, conviction-based buying from active funds, highlighted by a massive stake increase from Alyeska. $CRWV · High trading volume suggests significant market interest, but ownership is currently highly concentrated, with a notable presence of market-makers, leading to a neutral score that implies balanced risk/reward in the flow. $CLSK · Considered the best institutional structure in the group, combining broad, supportive passive index inclusion with aggressive, high-conviction active accumulation, suggesting the lowest qualitative risk. _ Comments: Eg. " Bullish - Jane Street + Citadel own x of $IREN " (hint: it's not positive). Especially when long term holders like FMR (Fidelity): 2.12M shares, trimmed large percent of stakes. The type of fund matters eg: Passive (Most Positive) Vanguard, BlackRock index, State Street, Geode, etc Long (Positive) Fidelity, T. Rowe, Wellington, BIT, etc Hedge Fund (Neutral to Positive) Alyeska, Coatue, Millennium, etc Quant/MM (Negative) Jane Street, Citadel, Susquehanna, SIG, Two Sigma, etc This is a subjective framework when scoring how positive flows were just from this quarter (not overall ownership).

The Neocloud List got updated: $IREN - IREN secured a $9.7B GPU cloud contract with Microsoft, including 20% upfront prepayment, to deploy NVIDIA GB300s over five years. $CIFR - CIFR secured a $5.5 billion, 15-year lease agreement with Amazon Web Services (AWS). The Neocloud sector just got insanely bullish with new contracts coming in from hyperscalers and this just shows insatiable demand for compute. I expected $ORCL, $META, and $AMZN to make deals in the original thesis and looks like AWS entered the fray with $CIFR, with likely more deals incoming with other Neoclouds. $META also signed a $14B deal with $CRWV recently and from their ER scaling AI Capex, we'll likely see other deals with Neoclouds. This is insanely bullish across the whole sector. I attached my personal tierlist for fun, but we'll likely see a re-ratings in data centers/miners across the board when there's more time to analyze deals and margins.

Pretty disgusting correction across the board. Last 5 days for high-beta growth stocks: • $SMCI -26.11% • $RKLB -19.85% • $CRCL -19.81% • $NBIS -19.14% • $WYFI -18.55% • $ALAB -16.64% • $CRDO -16.8% • $HOOD -14.36% • $ASTS -14.09% • $IREN -13.22% • $AMD -11.63% • $CIFR -10.05% • $RDDT -9.00% Speculative no revenue stocks like ( $RGTI -27.33%, $QBUT -25.5%, $QBTS -25.43%, $OKLO -17.04% etc), had larger corrections across the board. When the government reopens, I’d expect many of the speculative names to stay down, while companies where fundamentals are in tact (eg. $CIFR, $NBIS, $TSM, $HOOD, $RDDT) would recover. Current Contract Market data: Nov 12th-15th: 22% Nov 15th: 49% (~half chance sometime in the next week) Nov 30th: 92% Great time to position into higher-beta stocks during large corrections, (if fundamentals are in-tact), especially when we're in the extreme-fear part of markets and there's 75%+ of a third rate cut next month. Broad selloffs like these are also why you don't do short dated options <30dte, even if you are correct on earnings like $SNAP or $CIFR.

Lot of inspirational trader mindsets going around X lately like: "It will pay off. Be Patient". All BS. Traders consider sector momentum, catalysts, valuation, pullbacks, macro, IV, option flows, etc. Here's my mindset for short term trading for various stocks: 1. $NBIS - $111.91, even though it's up 1.53% on the day, CRWV is up 12% off Meta gives them a $14B contract. So usually it's bullish for all neoclouds. It spiked to $117 ( i probably would have still held) but pulled back to $111 likely from too much open interest, but we'll likely keep seeing a rally upward. So I'd use this time to DCA and buy calls/shares even if it's up 1.53% Not "truly a dip" but it's more of a dip during a rally. 2. $HIMS - $56.4 Down 4.67%, usually people just blindly buy the dip but this was actually caused from something material, which was Trump launching a direct to consumer GOV drug website. Short interest decreased back to 33% on the rise to $60. This dip will likely be used for short covering. I did buy $46 support but sold shortly on a bounce after I just felt like it would go down more. But I just personally prefer bottom entry points so that's probably closer to $50. I still remember AMZN launching a competitor, HIMS crashed 20% then rose again, I'd expect the same with Trump's program mid term but near term it's a headwind. 3. $RDDT - $228, down 5.45%, no news. Just probably valuation concerns. We saw similar growth stocks like ALAB, CRED, have random 20% pullbacks. Lot of software/social stocks like SNAP down 8.1% off non-material news. Correction is healthy, stocks don't just keep going up, I'd prefer to wait in the $100+ again, rather than $200+ (just personally), but it's actually a better buy than the rest, given RDDT has larger 5-8% pullbacks on random days, just from historical experiences so 6-7% drop is a good buy intra-day and you'd likely see it recover but we might see a lot of growth stocks have a larger correction into massive rally Nov/Dec so might not be an actual bottom. I don't really look at chart RSI nowadays, just do this based on feelings from experience looking at the stock + IV every day for the past year or two. 4. AMZN - No major macro news, prob government shutdown Oct 1st that might cause some panic for index but it's pretty immaterial. It dropped, 1.35% so I'd buy since it' a good time to cost average. 5. Klarna - $36, 5.3% drop. Sometimes you just go off gut feeling. Below IPO price, no major news. Most IPOs were down like Gemini, etc. If you wanted to build a long term position I'd buy at this level. 6. TSM - $277, I've been guilty of swing trading between $273-$279, so I just buy every drop to $273 and sell at $277-$279 for 2% profit purely with shares. So far I've done this ~2 times with shares. If it drops past $273, I'd just DCA and then if it drops further switch to calls. There's no True or False way to do this, everyone kind of has their own approach. (also sorry about CRM, bad earnings got that one wrong, I'll probably cost avg if ti declines further). But generally this is just what I'm thinking about when I go down the list of every single stock. Once again, everyone thinks differently, I just wanted to write down how I think if it's helpful to others.

It's sad how you're pumping a low mc stock that has a history of dumping dilution on shareholders. It's a cycle of hype -> stock rises -> dilution 70% under current prices -> shareholders get screwed. Decent thesis with other stocks but BKKT is a terrible shill to followers

I was looking at $SPRB after @MartinShkreli posted about it and it’s TA-ERT, breakthrough enzyme therapy replacement. Just from a quick search if SPRB’s TA-ERT is approved and they capture 10-15% market share longer term ($180–$270M ARR) of $1.4B US market... Realistic fair value today could be ~$280m-630m MC from 2-3x rev calculations. Obviously there’s a lot of risk from clinical failures, commercialization, to dilution but a $85M market cap looks promising? (disclosure I bought $50k worth just as a high risk gamble) Obviously I’m not an expert in biotech and this is outside my domain, which is why I wanted to see if anyone else with any domain knowledge had feedback or red flags.

Lot of inspirational trader mindsets going around X lately like: "It will pay off. Be Patient". All BS. Traders consider sector momentum, catalysts, valuation, pullbacks, macro, IV, option flows, etc. Here's my mindset for short term trading for various stocks: 1. $NBIS - $111.91, even though it's up 1.53% on the day, CRWV is up 12% off Meta gives them a $14B contract. So usually it's bullish for all neoclouds. It spiked to $117 ( i probably would have still held) but pulled back to $111 likely from too much open interest, but we'll likely keep seeing a rally upward. So I'd use this time to DCA and buy calls/shares even if it's up 1.53% Not "truly a dip" but it's more of a dip during a rally. 2. $HIMS - $56.4 Down 4.67%, usually people just blindly buy the dip but this was actually caused from something material, which was Trump launching a direct to consumer GOV drug website. Short interest decreased back to 33% on the rise to $60. This dip will likely be used for short covering. I did buy $46 support but sold shortly on a bounce after I just felt like it would go down more. But I just personally prefer bottom entry points so that's probably closer to $50. I still remember AMZN launching a competitor, HIMS crashed 20% then rose again, I'd expect the same with Trump's program mid term but near term it's a headwind. 3. $RDDT - $228, down 5.45%, no news. Just probably valuation concerns. We saw similar growth stocks like ALAB, CRED, have random 20% pullbacks. Lot of software/social stocks like SNAP down 8.1% off non-material news. Correction is healthy, stocks don't just keep going up, I'd prefer to wait in the $100+ again, rather than $200+ (just personally), but it's actually a better buy than the rest, given RDDT has larger 5-8% pullbacks on random days, just from historical experiences so 6-7% drop is a good buy intra-day and you'd likely see it recover but we might see a lot of growth stocks have a larger correction into massive rally Nov/Dec so might not be an actual bottom. I don't really look at chart RSI nowadays, just do this based on feelings from experience looking at the stock + IV every day for the past year or two. 4. AMZN - No major macro news, prob government shutdown Oct 1st that might cause some panic for index but it's pretty immaterial. It dropped, 1.35% so I'd buy since it' a good time to cost average. 5. Klarna - $36, 5.3% drop. Sometimes you just go off gut feeling. Below IPO price, no major news. Most IPOs were down like Gemini, etc. If you wanted to build a long term position I'd buy at this level. 6. TSM - $277, I've been guilty of swing trading between $273-$279, so I just buy every drop to $273 and sell at $277-$279 for 2% profit purely with shares. So far I've done this ~2 times with shares. If it drops past $273, I'd just DCA and then if it drops further switch to calls. There's no True or False way to do this, everyone kind of has their own approach. (also sorry about CRM, bad earnings got that one wrong, I'll probably cost avg if ti declines further). But generally this is just what I'm thinking about when I go down the list of every single stock. Once again, everyone thinks differently, I just wanted to write down how I think if it's helpful to others.